Ignite Creation Date:
2024-05-06 @ 1:34 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04053673
Status:
UNKNOWN
Last Update Posted:
2023-03-28
First Post:
2019-08-05
Brief Title:
Phase 1 Study of RBN-2397 an Oral PARP7 Inhibitor in Patients With Solid Tumors
Sponsor:
Ribon Therapeutics Inc
Organization:
Ribon Therapeutics Inc
Organization Data
Organization:
Ribon Therapeutics Inc
Class:
INDUSTRY
Study ID:
RBN-2397-19-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ribon Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None